ArticleInternational journal of medical sciences2024

Anlotinib suppresses the DNA damage response by disrupting SETD1A and inducing p53-dependent apoptosis in Transformed Follicular Lymphoma.

Xinguo Zhuang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.